ECSP993016A - THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR - Google Patents
THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATORInfo
- Publication number
- ECSP993016A ECSP993016A ECSP993016A ECSP993016A EC SP993016 A ECSP993016 A EC SP993016A EC SP993016 A ECSP993016 A EC SP993016A EC SP993016 A ECSP993016 A EC SP993016A
- Authority
- EC
- Ecuador
- Prior art keywords
- paratoroid
- compositions
- estrogen receptor
- selective estrogen
- combinations including
- Prior art date
Links
- 229940088597 hormone Drugs 0.000 title abstract 2
- 239000005556 hormone Substances 0.000 title abstract 2
- 102000015694 estrogen receptors Human genes 0.000 title 1
- 108010038795 estrogen receptors Proteins 0.000 title 1
- 230000001225 therapeutic effect Effects 0.000 title 1
- 239000000203 mixture Substances 0.000 abstract 3
- 238000000034 method Methods 0.000 abstract 2
- WRASVFOICVIUGY-UHFFFAOYSA-N 1-[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol Chemical compound OC1=CC=C2CCCCC2=C1C(C=C1)=CC=C1OCCN1CCCC1 WRASVFOICVIUGY-UHFFFAOYSA-N 0.000 abstract 1
- 208000001132 Osteoporosis Diseases 0.000 abstract 1
- 208000001164 Osteoporotic Fractures Diseases 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 239000012634 fragment Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Landscapes
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Esta invención se refiere a composiciones farmacéuticas de combinación y a procedimientos que comprenden (-) -cis-6-fenil-5-(4-(2-pirrolidin-1-il-etoxi)-fenil-5,6,7,8-tetrahidronaftalen-2-ol, o una de sus sales farmacéuticamente aceptables y hormona paratoroidea, o uno de sus fragmentos biológicamente activos, a procedimientos para usar dichas composiciones y a estuches que contienen dichas composiciones. Las composiciones son útiles para tratar fragilidad musculoesquelética, incluyendo osteoporosis, fractura osteoporótica, masa ósea reducida y fragilidad.This invention relates to combination pharmaceutical compositions and processes comprising (-) -cis-6-phenyl-5- (4- (2-pyrrolidin-1-yl-ethoxy) -phenyl-5,6,7,8- tetrahydronaphthalen-2-ol, or one of its pharmaceutically acceptable salts and paratoroid hormone, or one of its biologically active fragments, to procedures for using said compositions and to kits containing said compositions.The compositions are useful for treating musculoskeletal fragility, including osteoporosis, osteoporotic fracture, reduced bone mass and fragility.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993016 ECSP993016A (en) | 1999-06-15 | 1999-06-15 | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| ECSP993016 ECSP993016A (en) | 1999-06-15 | 1999-06-15 | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ECSP993016A true ECSP993016A (en) | 1999-08-12 |
Family
ID=42044005
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ECSP993016 ECSP993016A (en) | 1999-06-15 | 1999-06-15 | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR |
Country Status (1)
| Country | Link |
|---|---|
| EC (1) | ECSP993016A (en) |
-
1999
- 1999-06-15 EC ECSP993016 patent/ECSP993016A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IS2132B (en) | Use of estrogen for the manufacture of a medicinal product for the treatment of menopause | |
| ECSP055738A (en) | ENANTIOSELECTIVE PROCESS FOR THE PREPARATION OF BOTH ENANTIOMERS OF 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ- [b, f] -AZEPIN-5-CARBOXAMIDE AND ITS NEW GLASS FORMS | |
| TR200000927T2 (en) | Treatment of prostaglandin agonists and bone disorders | |
| AR005987A1 (en) | COMBINED THERAPY FOR OSTEOPOROSIS | |
| BR9714155A (en) | Prevention of bone mass loss and replacement by certain prostaglandin agonists. | |
| AP9801269A0 (en) | Prostaglandin agonists. | |
| ATE438618T1 (en) | INHIBITORS OF HUMAN ADAM-10 | |
| PA8471201A1 (en) | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE STROGEN RECEPTOR AND PARATHYROID HORMONE MODULATOR | |
| DK1420827T3 (en) | 5-CNAC sp, oral administration agent for parathyroid hormone fragments | |
| CY1117666T1 (en) | 4 - ((FAOXYLYL) SULFUR) -PHEOXIC ACIDS FOR USE IN THERAPEUTIC MEDICINE PURPOSES | |
| ID18079A (en) | PHARMACEUTICAL COMPOSITION THAT CONTAINS FASTEST OSTEOGENESIS | |
| DK1525215T3 (en) | Modulators for the progesterone receptor with elevated anti-gonadotropic activity for women's fertility control and hormone replacement therapy | |
| ECSP993016A (en) | THERAPEUTIC COMBINATIONS INCLUDING A SELECTIVE ESTROGEN RECEPTOR AND PARATOROID HORMONE MODULATOR | |
| PA8475901A1 (en) | COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITY | |
| NO20006381L (en) | Therapeutic combinations of (selective) estrogen receptor modulators (SERM) and growth hormone secretion agents | |
| DE69916932D1 (en) | Combination therapeutic agents containing a selective estrogen receptor modulator and prostaglandin E2 | |
| ECSP993020A (en) | COMBINATION THERAPY FOR MUSCULOSKELETAL FRAGILITY | |
| IT1307866B1 (en) | PHARMACEUTICAL COMPOSITIONS CONTAINING INHIBITORS OF GROWTH HORMONE OR THEIR BIOLOGICALLY ACTIVE FRAGMENTS FOR TREATMENT | |
| UY26651A1 (en) | COMBINED THERAPY FOR OSTEOPOROSIS | |
| ECSP993021A (en) | THERAPEUTIC COMBINATIONS FOR MUSCULOSKELETAL FRAGILITY | |
| UA28851A (en) | Method of operative treatment of the tibia distal epiphysis fructures |